Spots Global Cancer Trial Database for poziotinib twice daily dosing
Every month we try and update this database with for poziotinib twice daily dosing cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Poziotinib in Japanese Patients With NSCLC | NCT04402008 | NSCLC | Poziotinib Once... Poziotinib Twic... Poziotinib Once... | 20 Years - | Spectrum Pharmaceuticals, Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
